Jpmorgan Chase & CO United Therapeutics Corp Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in United Therapeutics Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 200,686 shares of UTHR stock, worth $60.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200,686
Previous 192,256 4.38%
Holding current value
$60.5 Million
Previous $67.8 Million 8.8%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$304.42 - $380.78 $2.57 Million - $3.21 Million
8,430 Added 4.38%
200,686 $61.9 Million
Q4 2024

Feb 12, 2025
SELL
$348.66 - $410.0 $101,111 - $118,900
-290 Reduced 0.15%
192,256 $67.8 Million
Q3 2024

Dec 26, 2024
BUY
$311.04 - $363.55 $15.6 Million - $18.3 Million
50,291 Added 35.35%
192,546 $69 Million
Q3 2024

Nov 08, 2024
BUY
$311.04 - $363.55 $15.6 Million - $18.3 Million
50,291 Added 35.35%
192,546 $69 Million
Q2 2024

Dec 26, 2024
SELL
$228.26 - $319.04 $11.5 Million - $16 Million
-50,291 Reduced 26.12%
142,255 $45.3 Million
Q2 2024

Aug 12, 2024
SELL
$228.26 - $319.04 $3.36 Million - $4.7 Million
-14,734 Reduced 9.39%
142,255 $45.3 Million
Q1 2024

Dec 26, 2024
SELL
$210.76 - $249.51 $7.49 Million - $8.87 Million
-35,557 Reduced 18.47%
156,989 $36.1 Million
Q1 2024

May 10, 2024
SELL
$210.76 - $249.51 $4.37 Million - $5.17 Million
-20,711 Reduced 11.66%
156,989 $36.1 Million
Q4 2023

Dec 26, 2024
SELL
$214.88 - $256.94 $3.19 Million - $3.81 Million
-14,846 Reduced 7.71%
177,700 $39.1 Million
Q4 2023

Feb 12, 2024
SELL
$214.88 - $256.94 $1.85 Million - $2.21 Million
-8,614 Reduced 4.62%
177,700 $39.1 Million
Q3 2023

Nov 14, 2023
SELL
$211.82 - $248.24 $3.36 Million - $3.93 Million
-15,839 Reduced 7.84%
186,314 $42.1 Million
Q2 2023

Aug 11, 2023
SELL
$205.19 - $232.99 $3.07 Million - $3.48 Million
-14,944 Reduced 6.88%
202,153 $44.6 Million
Q1 2023

May 18, 2023
BUY
$212.99 - $276.17 $16.7 Million - $21.6 Million
78,351 Added 56.47%
217,097 $48.6 Million
Q1 2023

May 11, 2023
SELL
$212.99 - $276.17 $9.26 Million - $12 Million
-43,471 Reduced 23.86%
138,746 $31.1 Million
Q4 2022

Feb 13, 2023
BUY
$205.95 - $280.43 $469,360 - $639,099
2,279 Added 1.27%
182,217 $50.7 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $809,947 - $972,773
-3,984 Reduced 2.17%
179,938 $37.7 Million
Q2 2022

Aug 11, 2022
SELL
$174.81 - $241.14 $2.03 Million - $2.79 Million
-11,585 Reduced 5.93%
183,922 $43.3 Million
Q1 2022

May 11, 2022
SELL
$166.16 - $213.96 $288,287 - $371,220
-1,735 Reduced 0.88%
195,507 $35.1 Million
Q4 2021

Feb 10, 2022
BUY
$184.32 - $216.08 $4.11 Million - $4.82 Million
22,287 Added 12.74%
197,242 $42.6 Million
Q3 2021

Nov 12, 2021
BUY
$179.86 - $214.88 $31.5 Million - $37.6 Million
174,955 New
174,955 $32.3 Million

Others Institutions Holding UTHR

# of Institutions
734
Shares Held
43M
Call Options Held
137K
Put Options Held
137K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $13.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email